Search
-
Getting to the HEART of Research
In February, we think about hearts not just in honor of Valentine’s Day but because it is American Heart Association Month. This is a great reminder to focus on our personal cardiovascular health. Renown Health helps patients think about their heart health with our world-class providers and cutting-edge treatments through our Cardiovascular Clinical Trials. “Research serves a vital role in the future care of cardiovascular diseases. Being involved in research will help our medical community to further discover new treatment plans in our quest for life preservation and extension,” Dr. Thomas To, Cardiologist and Researcher at Renown Health. For example, let’s talk about atherosclerosis. When our hearts are healthy, they are a strong muscle that pumps our oxygen-rich blood through our coronary arteries. Over time, cholesterol and fats can build up in our arteries. This is a condition known as atherosclerosis. This type of plaque buildup in the arteries can lead to a heart attack or stroke if not properly managed. If you are experiencing chest pain or discomfort, shortness of breath or pain in areas of the upper body, these can be the warning signs of a heart attack, and you should call 911. One contributing factor to atherosclerosis is elevated lipoprotein(a) levels and the accumulation of cholesterol in the arteries, which increases the likelihood of a heart attack or stroke. Lipoprotein(a) is tested separately from the standard panel that is completed for cholesterol management, and while your total cholesterol levels may be in a healthy range, lipoprotein(a) levels can still be elevated. "Increasingly we are realizing that lipoprotein(a) levels can be used as an important assessment in more carefully delineating an individual's risk of future cardiovascular events and treatment targets" said Dr. Michael Bloch, Lipid Specialist and Researcher at Renown Institute for Heart and Vascular Health. While it is clear that elevated lipoprotein(a) contributes to atherosclerosis, there are currently no approved medications for reducing cardiovascular disease risk through reducing lipoprotein(a) levels. This is why Renown Health’s Research Office is proud to offer a phase III clinical trial, called the OCEAN(a) study, to our patients with elevated lipoprotein(a) levels as a care option for management of their heart disease risk. Our teams of expert providers and researchers are here to support you on your healthcare journey. “I am thrilled to be able to be part of this study and bring opportunities like this to our patients. The highlight of my day is getting to hear life stories from my patients during our study visits,” Lisa Preciado, Primary Clinical Research Coordinator for the OCEAN(a) study said. Join us in raising awareness around American Heart Month by talking to your provider about lipoprotein(a) at your next appointment. At Renown Health, our goal is to make it easy for patients to access clinical research as a care opportunity where patients can access a variety of standard care treatment options for their health condition or choose to participate in a clinical trial. For more information about clinical trial opportunities available to you or to ask any questions, contact the Renown Research Office at Renown-CRD@renown.org or 775-982-3646.
-
Leading Experts Convene in Tahoe To Focus On Scientific Advancements And The Prevention Of Cardiovascular Disease, The #1 Cause Of Death Globally
Three-day medical education conference advances research, education, prevention and treatment. Physicians and medical professionals from across the country will convene in Lake Tahoe from Friday, Nov. 4 to Sunday, Nov. 6 to explore the most recent advances and established guidelines for the diagnosis, treatment and prevention of cardiovascular disease, diabetes mellitus, stroke and diseases or problems associated with heart disease. Hosted by Renown's Institute for Heart & Vascular Health and the Nevada Academy of Family Physicians, the 32nd annual three-day Trends in Cardiovascular Medicine conference will bring together national experts to explore challenges and solutions to cardiovascular diseases, the leading cause of death globally, taking an estimated 17.9 million lives each year. "The driving force behind this collaborative event is the shared missions of all our organizations, across the country, to advance progress in cardiovascular research, education, prevention and treatment," says Jayson Morgan, MD, FACC, Director of Cardiovascular Services at Renown. "We will be joined by colleagues from across the country including Mayo Clinic College of Medicine and Science in Rochester, UC San Francisco School of Medicine, David Geffen School of Medicine at UCLA, University of Washington Medical Center, University of Chicago Medicine and locally- with experts from Renown's Institute for Heart & Vascular Health/UNR Med and Northern Surgical Associates - to discuss contemporary trends in providing excellent cardiovascular care and prevention." New research will be presented each day from experts across the country, including the following topics: “What the Fentanyl? Making Sense of a Deadly Epidemic” “COVID-19: Return to Sport or Strenuous Activity Following Infection” “Management of Type 2 Diabetes: Evolving Data, Evolving Guidelines, Evolving Practice” “Coronary Microvascular Disease in Women: Signs, Symptoms, Evaluation and Treatment” “Lipoprotein (a): A Risk Factor for Atherosclerosis and an Emerging Therapeutic Target” “Gut Feeling: The Increased Importance of GLP-1 Therapies for Personalized Obesity Management” "Primary Care Perspectives: Peripheral Vascular Disease” “Prevention of Atrial Fibrillation and Sudden Cardiac Death in Women” “Clinical Practice Guidelines for the Management of Heart Failure in 2022: What Do I as a Primary Care Provider Need to Know?” “Can a Patient be Low Risk without a Calcium Score?” “Obesity & Cardiovascular Disease Risk Reduction: How Does Bariatric Surgery Change the Landscape?” To make an appointment with a provider at Renown's Institute for Heart and Vascular Health, request that your primary care provider make a referral. For more information on Renown's Institute for Heart and Vascular Health, visit renown.org/Health-Services/Heart-Care. About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.